Scott P. Levick

2.8k total citations
54 papers, 2.2k citations indexed

About

Scott P. Levick is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Scott P. Levick has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 17 papers in Immunology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Scott P. Levick's work include Cardiac Fibrosis and Remodeling (17 papers), Mast cells and histamine (14 papers) and Neuropeptides and Animal Physiology (12 papers). Scott P. Levick is often cited by papers focused on Cardiac Fibrosis and Remodeling (17 papers), Mast cells and histamine (14 papers) and Neuropeptides and Animal Physiology (12 papers). Scott P. Levick collaborates with scholars based in United States, Australia and Italy. Scott P. Levick's co-authors include Joseph S. Janicki, Gregory L. Brower, Giselle C. Meléndez, Jennifer L. McLarty, David B. Murray, Yan Du, Alexander Widiapradja, Jason D. Gardner, David Loch and Tetyana G Voloshenyuk and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and The FASEB Journal.

In The Last Decade

Scott P. Levick

52 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott P. Levick United States 25 1.2k 637 452 283 251 54 2.2k
Nour-Eddine Rhaleb United States 32 1.3k 1.1× 888 1.4× 490 1.1× 323 1.1× 278 1.1× 43 2.7k
Leif Erik Vinge Norway 27 1.1k 0.9× 1.5k 2.3× 332 0.7× 350 1.2× 180 0.7× 46 2.5k
Monique Freund France 32 1.1k 0.9× 692 1.1× 314 0.7× 445 1.6× 169 0.7× 68 3.3k
Gregory L. Brower United States 31 2.0k 1.7× 962 1.5× 584 1.3× 430 1.5× 346 1.4× 65 3.3k
Mei Zhang China 29 794 0.7× 930 1.5× 278 0.6× 517 1.8× 152 0.6× 104 2.4k
Shujiro Inoue Japan 19 548 0.5× 804 1.3× 592 1.3× 527 1.9× 235 0.9× 60 2.2k
Gen Takagi Japan 23 898 0.8× 996 1.6× 146 0.3× 424 1.5× 240 1.0× 57 2.0k
Mutsuo Harada Japan 18 954 0.8× 1.2k 1.9× 209 0.5× 405 1.4× 311 1.2× 34 2.3k
Toshihiro Tsuruda Japan 24 806 0.7× 822 1.3× 153 0.3× 372 1.3× 232 0.9× 70 2.0k
Donna S. Woulfe United States 25 586 0.5× 817 1.3× 305 0.7× 197 0.7× 109 0.4× 37 2.3k

Countries citing papers authored by Scott P. Levick

Since Specialization
Citations

This map shows the geographic impact of Scott P. Levick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott P. Levick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott P. Levick more than expected).

Fields of papers citing papers by Scott P. Levick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott P. Levick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott P. Levick. The network helps show where Scott P. Levick may publish in the future.

Co-authorship network of co-authors of Scott P. Levick

This figure shows the co-authorship network connecting the top 25 collaborators of Scott P. Levick. A scholar is included among the top collaborators of Scott P. Levick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott P. Levick. Scott P. Levick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levick, Scott P.. (2025). IgE and cardiac disease. Acta Physiologica. 241(2). e14281–e14281.
2.
Kriska, Tamás, Anja Herrnreiter, Sandra L. Pfister, et al.. (2024). Cellular metabolism of substance P produces neurokinin-1 receptor peptide agonists with diminished cyclic AMP signaling. American Journal of Physiology-Cell Physiology. 327(1). C151–C167.
3.
Widiapradja, Alexander, et al.. (2024). The orphan nuclear receptor Nr4a1 contributes to interstitial cardiac fibrosis via modulation of cardiac fibroblast and macrophage phenotype. Cellular and Molecular Life Sciences. 81(1). 484–484. 4 indexed citations
4.
Chunduri, Prasad, et al.. (2022). Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertension. Advances in pharmacology. 94. 183–211. 1 indexed citations
5.
Widiapradja, Alexander, James Peña, Paul H. Goldspink, et al.. (2019). Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart. Scientific Reports. 9(1). 11004–11004. 18 indexed citations
6.
Levick, Scott P., et al.. (2018). Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts. Heart Lung and Circulation. 28(10). 1598–1605. 53 indexed citations
7.
Janicki, Joseph S., Gregory L. Brower, & Scott P. Levick. (2014). The Emerging Prominence of the Cardiac Mast Cell as a Potent Mediator of Adverse Myocardial Remodeling. Methods in molecular biology. 1220. 121–139. 60 indexed citations
8.
Janicki, Joseph, J McLarty, Jianping Li, & Scott P. Levick. (2013). Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts. Journal of Inflammation Research. 6. 99–99. 14 indexed citations
9.
Levick, Scott P., et al.. (2013). Substance P in heart failure: The good and the bad. International Journal of Cardiology. 170(3). 270–277. 52 indexed citations
10.
Reimer, Michael, et al.. (2013). Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension. International Journal of Cardiology. 168(5). 4643–4651. 44 indexed citations
11.
McLarty, Jennifer L., Giselle C. Meléndez, William J. Spencer, et al.. (2011). Isolation of Functional Cardiac Immune Cells. Journal of Visualized Experiments. 7 indexed citations
12.
Meléndez, Giselle C., Jianping Li, Brittany A. Law, et al.. (2011). Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells. Cardiovascular Research. 92(3). 420–429. 54 indexed citations
13.
Levick, Scott P., Giselle C. Meléndez, Éric Plante, et al.. (2010). Cardiac mast cells: the centrepiece in adverse myocardial remodelling. Cardiovascular Research. 89(1). 12–19. 133 indexed citations
14.
Levick, Scott P., Tetyana G Voloshenyuk, David B. Murray, et al.. (2008). A novel technique for isolating functional mast cells from the heart. Inflammation Research. 57(5). 241–246. 17 indexed citations
15.
Levick, Scott P., Jason D. Gardner, Merrilee Holland, et al.. (2008). Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats. Journal of Molecular and Cellular Cardiology. 45(1). 56–61. 50 indexed citations
16.
Levick, Scott P., David Loch, Stephen M. Taylor, & Joseph S. Janicki. (2007). Arachidonic Acid Metabolism as a Potential Mediator of Cardiac Fibrosis Associated with Inflammation. The Journal of Immunology. 178(2). 641–646. 96 indexed citations
17.
Brower, Gregory L., Scott P. Levick, & Joseph S. Janicki. (2007). Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 292(6). H3057–H3064. 53 indexed citations
18.
Murray, David B., et al.. (2007). Response of cardiac mast cells to atrial natriuretic peptide. American Journal of Physiology-Heart and Circulatory Physiology. 293(2). H1216–H1222. 11 indexed citations
19.
Levick, Scott P., David Loch, Barbara E. Rolfe, et al.. (2006). Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats. The Journal of Immunology. 176(11). 7000–7007. 27 indexed citations
20.
Loch, David, Scott P. Levick, Andrew Hoey, & Lindsay Brown. (2006). Rosuvastatin Attenuates Hypertension-induced Cardiovascular Remodeling Without Affecting Blood Pressure in DOCA-salt Hypertensive Rats. Journal of Cardiovascular Pharmacology. 47(3). 396–404. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nour-Eddine Rhaleb Breakdown of academic impact, for papers by Leif Erik Vinge Breakdown of academic impact, for papers by Monique Freund Breakdown of academic impact, for papers by Gregory L. Brower Breakdown of academic impact, for papers by Mei Zhang Breakdown of academic impact, for papers by Shujiro Inoue Breakdown of academic impact, for papers by Gen Takagi Breakdown of academic impact, for papers by Mutsuo Harada Breakdown of academic impact, for papers by Toshihiro Tsuruda Breakdown of academic impact, for papers by Donna S. Woulfe
Rankless by CCL
2026